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Occlusion therapy throughout early childhood is believed to be efﬁcacious in treating deprivation
amblyopia but has not been rigorously assessed in clinical trials. Further, tools to assess adherence to
such therapy over an extended period of time are lacking. Using data from the Infant Aphakia Treatment
Study, a randomized clinical trial of treatment for unilateral congenital cataract, we examined the use of
quarterly 48-h recall interviews and annual 7-day prospective diaries to assess reported hours of
patching in 114 children throughout the ﬁrst 5 years of life. Consistency of data reported was assessed
using correlation coefﬁcients and intraclass correlation coefﬁcients. Both interview and diary data
showed excellent consistency with Cronbach’s Alpha’s ranging from 0.69 to 0.88 for hours of patching
and 0.60 to 0.73 for hours of sleep. However, caregivers reported somewhat more adherence in pro-
spective diaries than retrospective interviews. Completion rates, on the other hand, were substantially
higher for telephone interviews than prospective diaries. For example, four years after surgery response
rates to telephone interviews exceeded 75% versus completion rates of only 54% for diaries. In situations
where occlusion dose monitors cannot be used for assessing adherence to occlusion therapy, such as in
infants or over an extended period of time, quantitative assessments of occlusion therapy can be ob-
tained by parental report, either as a series of prospective diaries or a series of recall interviews.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Deprivation amblyopia, such as that caused by unilateral in-
fantile cataract, requires long-term occlusion of the unaffected eye
[1,2]. Although occlusion is a standard part of treatment, its efﬁcacy
has not been rigorously assessed [3]. Further, because occlusion is
often difﬁcult for caregivers to administer [4,5], there is a high-level
of non-concordance between prescribed and achieved occlusion
[6e11]. Thus, the ability to assess adherence to occlusion therapy is
important for clinicians caring for, as well as researchers.
Standard methods for assessing adherence to occlusion are not
available. The assessment of adherence has utilized qualitativelens; IATS, Infant Aphakia
onitors.
ogy, Rollins School of Public
17, Mailstop: 1518-002-3BB,
sch).
Inc. This is an open access article uparental questionnaires [4,6,7,10] parental report combined with
attendance at clinic visits [12], diaries and recall interviews [8,13],
and occlusion dose monitors (ODMs) [14e18]. ODMs have the po-
tential advantage of providing quantitative data [14e16,18,19] and
have been successfully used over short periods of time (e.g., <6
months) in older children. However, these methods are often
supplemented with patching diaries because of concerns about
battery life and/or other technical problems [20]. Further, ODM use
in infants may be unacceptable to caregivers, and may not be
tolerated extended periods. ODMs also are less accurate in higher
ambient temperatures and less reliable when the patch is worn
under spectacles [21]. Finally, ODMs are not yet commercially
available in the United States. Patching diaries can produce quan-
titative estimates of occlusion that correlate well with estimates
obtained using ODMs [15,16], but have been criticized for over-
estimating adherence [22] and for being unreliable [15,23].
Thus, there is a need to develop and assess methods to assess
adherence to prescribed patching over extended periods, starting in
infancy. The Infant Aphakia Treatment Study (IATS) presented thisnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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were to determine whether caregivers could reliably report
adherence to prescribed patching in retrospective telephone in-
terviews and/or prospective diaries, and the relative costs and
beneﬁts of assessing adherence using these two methods.
2. Methods
2.1. Subjects and methods
The overall design of the IATS and results of the visual acuity
assessment at 4.5 years of age have previously been published
[24e26]. Brieﬂy, the IATS was a randomized controlled trial
comparing two treatments for unilateral congenital cataract in in-
fants undergoing cataract extraction between 28 days and 7
months of age: contact lens (CL) correction of aphakia versus pri-
mary intra-ocular lens (IOL) implantationwith spectacle correction
of residual refractive error if needed. The study was approved by
the institutional review boards of all participating institutions and
was in accordance with the tenets of the Declaration of Helsinki.
2.2. Prescribed patching and visual correction
Patching was prescribed for all patients until their ﬁfth birthday.
Starting the second week after cataract surgery, caregivers were
instructed to have the child wear an adhesive occlusive patch over
the fellow eye 1 h daily per month of age until the child was eight
months old. Thereafter, caregivers were told to patch their child
50% of waking hours. Patches were provided to patients at no cost
to minimize ﬁnancial barriers to patching. Deviations from pre-
scribed patching protocols, both over- and under-patching, were
not considered to be protocol violations.
Refractive correction was prescribed for all children 100% of
waking hours. Within a week after cataract surgery, patients ran-
domized to the CL group were ﬁtted with a silicone (Silsoft; Bausch
& Lomb, Rochester, New York) or a rigid gas permeable contact lens
with a 2.0-D overcorrection to provide a near-point correction.
Parents were provided with a spare contact lens. Both daily wear
and extended wear protocols were acceptable, given the prefer-
ences of the treating physicians. At 2 years of age, the eye was
corrected to emmetropia using a CL, and spectacles were prescribed
with a D segment bifocal lens with an add of þ3.0 D for near focus.
For infants randomized to the IOL group, spectacles were pre-
scribed by the 1-month postoperative visit if any of the following
conditions existed: hyperopia of more than 1.0 D, myopia of more
than 3.0 D, or astigmatism of more than 1.5 D. In children younger
than 2 years, the aim was to correct the refractive error to 2.0 D of
myopia, whereas in children 2 years or older, the aim was emme-
tropia at distance with a near correction of þ3.0 D. The phakic eye
for both groups was corrected with spectacles if 1 of the following
conditions existed: hyperopia> 5.0 D, myopia> 5.0 D, astigma-
tism> 1.5 D, or refractive esotropia. The aim was to correct the
refractive error to the range of 0 to þ3.0 D in the phakic eye. When
required, spectacles were to be worn 100% of waking hours.
2.3. Assessment of adherence
Adherence to prescribed patching and refractive correction, and
hours of sleep were reported by caregivers using two different
methodologies: a retrospective telephone interview every 3
months and an annual prospective diary. The telephone interview
and diary collected similar information. In the diary parents re-
ported sleep patterns, patch use, contact lens wear and spectacle
wear over a seven day prospective period (see appendix). Diaries
were completed two months after surgery and at 13, 25, 37 and 49months of age. The diary was mailed to the caregiver, who returned
the diary to the DCC following completion. A staff member called
the caregiver after mailing the diary to ensure that the diary had
been received and to remind the caregiver to begin documenting
use of the patch.
The telephone interviews were completed quarterly, starting 3
months after surgery and continuing until the child was ﬁve years
of age, and used a semi-structured interview to elicit the same
information as reported on the patching diary for the previous 48-
h. The timing of the interview was determined using an algorithm
that distributed the preferred day of the call evenly throughout the
week since patching has been reported to differ on weekdays and
weekend days [18]. Caregivers were not informed in advance about
the speciﬁc day or times of the interview. The interviews were
conducted by one of three trained interviewers (one English-
speaking, one Spanish-speaking, and one Portuguese-speaking) in
the caregiver’s primary language so that the caregiver was inter-
viewed by the same person on each occasion. The vast majority of
interviews (>95%) were performed by the English-speaking inter-
viewer. The interviewers were located at the Data Coordinating
Center to minimize the possibility that the respondent would
exaggerate their adherence or that the interviewer’s interpretation
of the information would be biased by knowledge of the child’s
visual acuity or treatment.
Measures of adherence were derived from caregivers’ reports
regarding the times that patch was placed and removed. Similar
data were available regarding CL wear, spectacle wear and sleep.
We used this information to calculate the number of hours per day
that the patch was worn, and the number of hours that the child
slept each day. For diaries, this represented an average over the 7
days covered by the diary; for interviews, this represented an
average over 48 h. For purposes of the current analysis, we did not
assess adherence to contact lens and spectacle wear because of the
wide variety of prescribed regimens associated with refractive
correction.2.4. Analytic methods
Analyses were conducted using SPSS 21 (IBM Corp. Released
2012. IBM SPSS Statistics for Windows, Version 21.0. Armonk, NY:
IBM Corp) and SAS 9.2 (SAS Institute Inc. Cary, NC) statistical
packages. Intraclass correlation coefﬁcients were used to assess the
consistency of reports of daily hours of patching and sleep over
time. Pearson’s correlation coefﬁcients were used to compare daily
hours of patching and sleep reported on each diary to the same
information reported on the closest 48-h interview. Similarly, we
estimated the mean difference in number of hours of patching re-
ported on diaries to the same information reported on the closest
48-h interview to determine whether information reported on di-
aries differed systematically from information reported in the
interviews.3. Results
114 infants participated in IATS: 57 were randomized to receive
an IOL at the time of cataract extraction and 57 were randomized to
remain aphakic (Fig. 1). Surgery was performed on all infants be-
tween 28 days and 7months of life. Additional details regarding the
population are provided in other publications [25,26]. The current
analyses exclude two children for whom patching of the fellow eye
was discontinued because of adverse events resulting in loss of
visual potential in the treated eye (n ¼ 2) and a third child with
Stickler’s Syndromewho had better vision in the treated eye than in
the fellow eye.
Fig. 1. Consort diagram for the Infant Aphakia Treatment Study.
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Fig. 2 shows completion rates for the 48-h interviews by time
since surgery (panel a) and the diaries by age (panel b). On average,
completion rates were higher for the 48-h recall interviews than for
the prospective diaries. For example, 87% of caregivers completed
the ﬁrst diary two months after surgery; one month later the
completion rate for the 48-h interview was ten percent higher
(97%). The completion rates of both interviews and diaries declined
over time. Even so, nearly ﬁve years after surgery, the interviews
were completed by nearly three-quarters of caregivers (73%) while
only about half (54%) of the caregivers returned the diary when the
children were four years of age. Forty-three (38%) of the caregivers
completed all ﬁve diaries and an additional 24 (21%) completed
four of ﬁve diaries. Eight (7.0%) caregivers did not complete any of
the diaries. On the other hand, all caregivers completed at least four
of the 48-h recall interviews and nearly two-thirds (n ¼ 71, 62.2%)
completed 17 or more interviews. All participants had adherence
data available for the ﬁrst year following surgery with three-
quarters (n ¼ 89, 78.1%) completing all ﬁve possible assessments
in this ﬁrst year. Although there was some tendency for caregiverswho did not provide adherence data at subsequent time points to
report less adherence with occlusion than those who did provide
data, these differences were neither consistent nor did they
approach statistical signiﬁcance (data not shown).
Substantial effort was required to collect these data. Half of all
interviews were completed within two phone calls, regardless of
the time since surgery. However, numerous attempts were required
to successfully collect data on some participants. For example, at
nearly all time points, more than 10 contact attempts were required
in order to collect data on one or more participants.
3.2. Agreement between patching reports
There was substantial inter- and intra-subject variation in the
amount of patching reported. For example, in the ﬁrst twelve
months after surgery, the range of average hours of patching per
day ranged from 0.37 to 7.63 and the interquartile range of reported
adherence ranged from just under 3 h per day to nearly 5 ½ hours.
The intra-subject variation in reported hours of patching per day is
demonstrated in Fig. 3 which shows the reported hours of patching
by age for the ﬁve participants who completed at least sixteen
ab
Fig. 2. Completion Rates for Interviews (panel a) and Diaries (panel b) by Time since Surgery.
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per day was between 3.8 and 4.2 h, which was approximately the
median amount of patching reported. Such variation was not pre-
sent for reported hours of sleeping per day (see appendix).
Even considering the high degree of intra-subject variation in
patching, data on adherence to patching were highly correlated
with the same data reported three months later and were more
strongly associated than were reports of hours of sleep per night(correlation coefﬁcients ranging from 0.59 to 0.83 for occlusion and
from 0.13 to 0.60 for hours of sleep). Further, the data reported on
interviews and data reported on diaries were highly consistent. For
example, the Cronbach’s Alpha for the four interviews conducted
within the ﬁrst twelve months after surgery is 0.69 for reported
hours of patching per day and 0.67 for reported hours of sleep each
night (Table 1). Additionally, daily hours of patching reported on
each diary was strongly correlated with data reported by the
Fig. 3. Reported daily hours of patching by age at assessment for 5 selected participants with reported patching that averaged between 3.8 and 4.2 h per day.
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However, in general, caregivers reported more patching on diaries
than on interviews, even when these assessments were reported
around the same age, and the 95% conﬁdence interval for this dif-
ference excluded the null at 13 and 25 months of age.4. Discussion
The IATS experience provides information on assessing adher-
ence to occlusion and visual correction in very young children in a
clinical trial of treatment for unilateral congenital cataracts. Our
ﬁndings suggest that caregivers can report information that can be
used to distinguish families who are able to adhere to prescribed
post-surgical treatment from those who struggle with patching.
Such data are of importance in both research and clinical practice.
In particular, a recent Cochrane Review recently recommended
clinical trials be conducted to evaluate the efﬁcacy of occlusion
therapy for children with stimulus deprivation amblyopia, such as
caused by unilateral cataract [3]. The methods we investigate here
would allow for a quantitative estimation of adherence to occlusionTable 1
Consistency of reported average waking hours patched per day by method of data collec
N
Interviews conducted in 1st year post surgerya 93
Interviews conducted in 2nd year post surgeryb 86
Interviews conducted in 3rd year post surgeryc 71
Interviews conducted in 4th year post surgeryd 62
All Diariese 43
a Interviews conducted 3, 6, 9 and 12 months after surgery.
b Interviews conducted 15, 18, 21 and 21 months after surgery.
c Interviews conducted 24, 27, 30, and 33 months after surgery.
d Interviews 36, 39, 42 and 45 months after surgery.
e Diaries 2 months after surgery and at 14, 26, 38 and 50 months of age.therapy in such a trial. However, our data suggest that collecting
these data requires a signiﬁcant investment of resources in order to
provide a relatively complete picture of adherence in young
children.
These ﬁndings conﬁrm reports that there is a high degree of
intra- and inter-individual variability in reported adherence to
patching [5], which is likely to reﬂect true variability in adherence
day to day, as well as over more extended time periods such as the
ﬁve year follow-up reported here. Further, our data highlight the
potential differences between the dose rate, deﬁned as the average
number of hours of patching per day, and the accumulated dose of
occlusion, deﬁned as the total amount of patching experienced by a
child [15]. Thus, for conditions, such as unilateral cataract, where
occlusion therapy is prescribed formonths, or even years, collecting
these data over time provides a fuller picture of accumulated dose
of patching.
Frequent contact with families demonstrated to caregivers that
the study had a sincere interest in their child and allowed strong
relationships between caregivers and study staff to develop, which
may be an additional beneﬁt of collecting these data on a regulartion.
Waking hours patched per day
Median (IQR) Cronbach’s alpha (95% CI)
4.09 (2.80,5.44) 0.69 (0.58,0.8)
3.41 (1.43,5.00) 0.85 (0.79,0.90)
3.51 (1.96,5.46) 0.88 (0.82,0.92)
3.41 (1.73,5.52) 0.87 (0.82,0.92)
3.79 (1.73,5.00) 0.86 (0.78,0.92)
Table 2
Correlationa between adherence reported on the 7-day prospective diary and adherence reported on the 48-h telephone recall interview closest in time to the diary.
N Days between diary and interviewb mean þ SD (range) Correlationc Reported waking hours
patched
Mean difference (95% CI)
48-h interview 7-Day diary
2 months after surgeryd 98 19.07 ± 13.03 (64,33) 0.384 4.27 ± 2.03 3.91 ± 1.65 0.36 (0.05,0.77)
13 months of age 84 1.00 ± 30.41 (50,54) 0.765 3.68 ± 2.36 4.22 ± 1.87 0.54 (0.88,0.21)
25 months of age 73 8.30 ± 22.42 (57,46) 0.752 3.64 ± 2.66 4.15 ± 2.32 0.59 (0.93,0.09)
37 months of age 56 1.84 ± 25.34 (45,53) 0.848 4.10 ± 2.98 3.89 ± 2.35 0.21 (0.22,0.63)
49 months of age 55 3.96 ± 27.30 (57,58) 0.647 3.22 ± 2.79 3.51 ± 2.49 0.29 (0.91,0.32)
a All correlations were statistically signiﬁcant, p < 0.001.
b Diary - Interview.
c Pearson’s Correlation Coefﬁcient between data reported on the 48-Hour Telephone Interview and data reported on the 7-Day Diary.
d Note: According to the patching protocol, patching in the 7-day diary conducted 2 months after surgery should be, on average, 1 h less than patching at the 1st interview
which was conducted 3 months after surgery.
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participants was 100% for the assessment of visual acuity at twelve
months of age [27] and 99% at age 4.5 years [26]. We ascribe at least
some of the successful follow-up of these participants to the
interpersonal relationships that families developed with the staff
who completed the 48-h interviews every 3 months.
These data demonstrate that caregivers can continue to suc-
cessfully patch their young children over an extended period of
time, even if during speciﬁc periods, they achieve only minimal
patching. As evidenced in Fig. 2, a number of caregivers reported
very little patching at some points, but reported being able to
successfully occlude their child on subsequent assessments. The
message that suboptimal patching at one point in time does not
mean that the child cannot achieve an adequate accumulated dose
of patching is an important message for caregivers, particularly
during the second and third years of life when young children may
express more resistance to patching [7,28].
A number of investigators have suggested that adherence to
patching is more accurately estimated using Occlusion Dose Mon-
itors (ODM) than using parental report. They further suggest that
parental reports overestimate adherence to occlusion, are not free
from bias and require observation of entire treatment period [15]. It
is possible that the amount of patching that we report here is
overestimated. However, previous reports have shown good re-
lationships between occlusion measured via parental diary and
ODM. Further, in the current study, caregivers reported an average
of three to 4 h of occlusion per day, a level which is similar to the
average adherence to occlusion reported in a number of studies
which used ODMs to assess adherence [16]. However, the amount
of patching that we report is somewhat higher than that provided
by other reports [29,30]. This may reﬂect the support, such as
newsletters and free patches that were provided to caregivers as
part of IATS.
Ourmethods can be used in situations inwhich ODMsmight not
be appropriate or acceptable. In our own study, for example, ODMs
were not deemed acceptable for use with infants and other young
children because of parental and IRB concerns about risks associ-
ated with the devices. Additionally, wemonitored adherence over a
nearly ﬁve year period. It may be difﬁcult to use ODMs over this
extended time. Finally, using parental reports, we were able to
successfully monitor adherence on both occlusion and use of con-
tact lenses and spectacles. As currently conﬁgured, ODMs are only
able to monitor adherence to the use of eye patches for occlusion.
Methods to separately monitor adherence to spectacle use and
occlusion are under development [21].
We suggest some caution in interpreting our ﬁndings and in
applying them in other contexts. Wewere able to collect adherence
data from all caregivers in the ﬁrst year after surgery, 111 caregivers
in the second year, 95 caregivers in the third year, 94 caregivers in
the fourth year and 91 caregivers in the ﬁfth year of follow up.However, for some speciﬁc time periods, the number of re-
spondents is relatively small. This is particularly true for the diary at
around four years of age, whichwas completed by only about half of
participants. Additionally, only 43 (38%) caregivers completed all
ﬁve diaries. If higher levels of adherence are reported by caregivers
who returned all the diaries, our estimates of the number of hours
of patching reported by caregivers could be overestimated.We have
little evidence to suggest that this occurred, however, as the re-
ported number of hours of patching on each diary was not signif-
icantly associated with the likelihood of responding to the all
diaries (See Supplemental Table 2).
We also suggest caution in applying our estimates of the amount
of patching achieved by caregivers to other contexts. We expect
that adherence to both patching and visual correction obtained in
IATS may be higher than is usual because the IATS provided glasses,
contact lenses and patches to families. Thus, there may have been
fewer ﬁnancial barriers to adhering to prescribed post-surgical
treatment than in other situations. Also the quarterly interviews
and clinic visits may have provided additional motivation and
support to families to continue occlusion therapy.
We further note that the caregivers were aware that these data
were collected independently of the clinical staff that was moni-
toring their children’s visual acuity and ocular health. It is thus
possible that the data from caregivers of IATS participants were less
subject to social desirability bias than that obtained in other con-
texts. Further, these data are unlikely to be comparable to quali-
tative data assessed by clinicians in an ofﬁce context where both
social desirability and the results of visual acuity assessments
might impact the assessment.
In summary, we believe that our ﬁndings show that adherence
to patching and visual occlusion can be successfully reported by
caregivers of infants and young children over an extended period of
time. We further conclude that, although either prospective diaries
or retrospective telephone interviews may be used to gather
quantitative estimates of patching, obtaining data via quarterly
telephone interview may be preferred given the higher completion
rates obtained. Additionally, the frequent telephone contact may
have an added beneﬁt of enhancing retention in clinical research.
Thus, it is possible that if we had performed additional telephone
reminders the completion rates for the diaries might have
improved. However, our ﬁndings suggest that collecting these data
requires a substantial commitment of resources on the part of the
investigators.
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